Company Profiles

driven by the PitchBook Platform

Aelix Therapeutics

Description

Developer of a new therapeutic vaccine for HIV. The company engages in developing immunotherapies that are used for treating HIV infection.

2015

Founded

PRIVATE

Status

Series A

Latest Deal Type

$13M

Latest Deal Amount

$13M

Total Amount Raised

3

Investors

Description

Developer of a new therapeutic vaccine for HIV. The company engages in developing immunotherapies that are used for treating HIV infection.

Website:

www.aelixtherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

Cl Baldiri I Reixac, 4-8 08028 BarcelonaSpain
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aelix Therapeutics's full profile, request a free trial.

    Aelix Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aelix Therapeutics Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Caixa Capital RiscCorporate Venture CapitalMinority000 0000000 0000
    Johnson & Johnson Innovation - JJDCCorporate Venture CapitalMinority000 0000000 0000
    Ysios Capital PartnersVenture CapitalMinority000 0000000 0000
    Caixa Capital Risc Corporate Venture Capital
    Johnson & Johnson Innovation - JJDC Corporate Venture Capital
    Ysios Capital Partners Venture Capital

    Aelix Therapeutics Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Christian Brander Ph.DChief Scientific Officer & Co-Founder
    Jordi NavalCo-Founder & Board Member
    Bonaventura ClotetCo-Founder
    Josep Maria GatellCo-Founder
    Christian Brander Ph.D Chief Scientific Officer & Co-Founder
    Jordi Naval Co-Founder & Board Member
    Bonaventura Clotet Co-Founder
    Josep Maria Gatell Co-Founder

    Aelix Therapeutics Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Jeanne BolgerJohnson & Johnson Innovation - JJDCVice President, Venture Investments000 0000
    Jordi NavalAelix TherapeuticsCo-Founder & Board Member000 0000
    José Antonio MesaCaixa Capital RiscInvestment Director000 0000
    Karen WagnerYsios Capital PartnersGeneral Partner000 0000
    Jeanne Bolger Vice President, Venture Investments Johnson & Johnson Innovation - JJDC
    Jordi Naval Co-Founder & Board Member Aelix Therapeutics
    José Antonio Mesa Investment Director Caixa Capital Risc
    Karen Wagner General Partner Ysios Capital Partners
    Request full access to PitchBook